STEPS TO STUDY ACTIVATION
Study is IRB Approved
Obtaining IRB Approval is one of the major milestones in the study activation process. Review the Submit to IU Institutional Review Board (IU IRB) page for more information about the IU IRB Submission and Approval process.
If your study record has been created in OnCore, confirm or document your IRB approvals in the IRB Reviews tab. Review the Study Receives All Signoffs in OnCore tile for more information and helpful resources.
If your study was reviewed by the OCR Financial Compliance team, please provide your final IRB approved Informed Consent document to ocrfin@iu.edu so that a Final Review can be completed.
IU Simon Comprehensive Cancer Center (IUSCCC) Additional Information
For Cancer Center Trials (studies involving cancer patients):
For studies involving the Cancer Center’s Adult Clinical Trials Office (CTO), please reach out to cto-finance-l@list.iu.edu for support with the study activation process.
For studies involving the Pediatric Hematology/Oncology/Stem Cell Clinical Research Team, please reach out to rileyphosresearchteam@iuhealth.org for support with the study activation process.
Obtaining IRB approval is one of the major prerequisite milestones in the study activation process, but all additional requirements should be reviewed using the Clinical Research Roadmap.